[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1122819A1 - Novel peptide compounds from wilms' tumor - Google Patents

Novel peptide compounds from wilms' tumor

Info

Publication number
HK1122819A1
HK1122819A1 HK08113820.1A HK08113820A HK1122819A1 HK 1122819 A1 HK1122819 A1 HK 1122819A1 HK 08113820 A HK08113820 A HK 08113820A HK 1122819 A1 HK1122819 A1 HK 1122819A1
Authority
HK
Hong Kong
Prior art keywords
wilms
tumor
peptide compounds
novel peptide
novel
Prior art date
Application number
HK08113820.1A
Other languages
English (en)
Inventor
Toshio Nishihara
Masashi Gotoh
Original Assignee
Int Inst Cancer Immunology Inc
Chugai Pharmaceutical Co Ltd
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Int Inst Cancer Immunology Inc, Chugai Pharmaceutical Co Ltd, Dainippon Sumitomo Pharma Co filed Critical Int Inst Cancer Immunology Inc
Publication of HK1122819A1 publication Critical patent/HK1122819A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001152—Transcription factors, e.g. SOX or c-MYC
    • A61K39/001153—Wilms tumor 1 [WT1]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK08113820.1A 2005-11-30 2008-12-19 Novel peptide compounds from wilms' tumor HK1122819A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005346577 2005-11-30
PCT/JP2006/323827 WO2007063903A1 (ja) 2005-11-30 2006-11-29 新規ペプチド化合物

Publications (1)

Publication Number Publication Date
HK1122819A1 true HK1122819A1 (en) 2009-05-29

Family

ID=38092236

Family Applications (2)

Application Number Title Priority Date Filing Date
HK08113820.1A HK1122819A1 (en) 2005-11-30 2008-12-19 Novel peptide compounds from wilms' tumor
HK16109195.6A HK1221230A1 (zh) 2005-11-30 2016-08-02 新型肽化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK16109195.6A HK1221230A1 (zh) 2005-11-30 2016-08-02 新型肽化合物

Country Status (18)

Country Link
US (4) US7939627B2 (xx)
EP (1) EP1961761B1 (xx)
JP (4) JP4394724B2 (xx)
KR (1) KR101385805B1 (xx)
CN (2) CN101336249A (xx)
AU (1) AU2006319892B2 (xx)
BR (1) BRPI0619255B8 (xx)
CA (1) CA2631292C (xx)
DE (1) DE602006017880D1 (xx)
DK (1) DK1961761T3 (xx)
ES (1) ES2352855T3 (xx)
HK (2) HK1122819A1 (xx)
PL (1) PL1961761T3 (xx)
PT (1) PT1961761E (xx)
RU (1) RU2424247C2 (xx)
SI (1) SI1961761T1 (xx)
TW (1) TWI372152B (xx)
WO (1) WO2007063903A1 (xx)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2071028T3 (pl) 2003-11-05 2012-06-29 Int Inst Cancer Immunology Inc Pochodzący z WT1 peptyd antygenowy wiążący się z HLA-DR
CA2626238C (en) 2005-10-17 2015-10-06 Sloan Kettering Institute For Cancer Research Wt1 hla class ii-binding peptides and compositions and methods comprising same
SI1961761T1 (sl) * 2005-11-30 2010-12-31 Int Inst Cancer Immunology Inc Nove peptidne spojine iz Wilmsovega tumorja
EP3834836A1 (en) 2006-04-10 2021-06-16 Memorial Sloan Kettering Cancer Center Immunogenic wt-1 peptides and uses thereof
AU2008220031B2 (en) 2007-02-27 2013-06-13 International Institute Of Cancer Immunology, Inc. Method for activation of helper T cell and composition for use in the method
JP2011016751A (ja) * 2009-07-08 2011-01-27 Sumitomo Chemical Co Ltd 光学活性３−アミノピペリジン−１−カルボキシレート化合物の製造方法およびその製造方法に用いられる中間体
HUE047521T2 (hu) 2010-03-31 2020-04-28 Stabilitech Biopharma Ltd Vírusrészecskék stabilizálása
ES2617921T3 (es) 2010-03-31 2017-06-20 Stabilitech Ltd. Excipientes para estabilizar partículas virales
BR112012025044A2 (pt) 2010-03-31 2016-06-21 Stabilitech Ltd método para conservar adjuvantes de alum e vacinas com adjuvantes de alum
BR112013008230A2 (pt) 2010-10-05 2016-06-14 Int Inst Cancer Immunology Inc método para ativar célula t auxiliar
GB201117233D0 (en) 2011-10-05 2011-11-16 Stabilitech Ltd Stabilisation of polypeptides
US9539299B2 (en) * 2011-10-27 2017-01-10 International Institute Of Cancer Immunology, Inc. Combination therapy with WT1 peptide vaccine and temozolomide
US20150104413A1 (en) * 2012-01-13 2015-04-16 Memorial Sloan Kettering Cancer Center Immunogenic wt-1 peptides and methods of use thereof
US20150150975A1 (en) 2012-07-02 2015-06-04 Sumitomo Dainippon Pharma Co., Ltd. Transdermal cancer antigen peptide preparation
RU2644677C2 (ru) * 2012-12-13 2018-02-13 Рупрехт-Карлс-Университэт Гейдельберг Мсн-специфичные пептиды со смещенной рамкой считывания (псрс) для предотвращения и лечения рака
CN110195040A (zh) 2012-12-17 2019-09-03 大塚制药株式会社 辅助性t细胞的活化方法
RS61173B1 (sr) * 2013-01-15 2021-01-29 Memorial Sloan Kettering Cancer Center Imunogeni wt-1 peptidi i postupci za njihovu upotrebu
US10815273B2 (en) 2013-01-15 2020-10-27 Memorial Sloan Kettering Cancer Center Immunogenic WT-1 peptides and methods of use thereof
KR20140100416A (ko) 2013-02-05 2014-08-14 닛토덴코 가부시키가이샤 경피 투여용 ｗｔ1 펩티드 암 백신 조성물
CN103961307B (zh) 2013-02-05 2019-11-29 日东电工株式会社 经皮给予用wt1肽癌症疫苗组合物
IN2014CH00393A (xx) 2013-02-05 2015-04-03 Nitto Denko Corp
CN103961702B (zh) 2013-02-05 2019-04-09 日东电工株式会社 粘膜给予用wt1肽癌症疫苗组合物
RU2627175C2 (ru) * 2013-03-08 2017-08-03 Тайхо Фармасьютикал Ко., Лтд. Новый пептид, имеющий 5 соединенных эпитопов ctl
CN105142656B (zh) 2013-03-12 2019-05-10 大日本住友制药株式会社 水性液体组合物
EP2980097A4 (en) * 2013-03-29 2017-03-08 Sumitomo Dainippon Pharma Co., Ltd. Conjugate vaccine using trimming function of erap1
WO2014157692A1 (ja) 2013-03-29 2014-10-02 大日本住友製薬株式会社 Ｗｔ１抗原ペプチドコンジュゲートワクチン
PT3061771T (pt) 2013-10-21 2020-05-06 Taiho Pharmaceutical Co Ltd Novo péptido unido a quatro epitopos ctl
GB201406569D0 (en) 2014-04-11 2014-05-28 Stabilitech Ltd Vaccine compositions
CA2962630C (en) 2014-09-27 2023-02-21 Sumitomo Dainippon Pharma Co., Ltd. Pharmaceutical composition for injection
JP6671141B2 (ja) * 2014-10-21 2020-03-25 大日本住友製薬株式会社 懸濁液剤
JP6699013B2 (ja) * 2014-12-25 2020-05-27 国立大学法人三重大学 Ｗｔ１由来ペプチド認識抗体
EP3549957A4 (en) 2016-11-30 2020-08-05 Sumitomo Dainippon Pharma Co., Ltd. WT1-HELPER PEPTIDE AND COMBINATION OF THE SAYING PEPTIDE AND A CANCER ANTIGEN PEPTIDE CONJUGATE
EP3604325A4 (en) 2017-03-30 2021-01-13 Sumitomo Dainippon Pharma Co., Ltd. WT1 CANCER ANTIGEN PEPTIDE AND PEPTIDE CONJUGATE BODY WITH IT
GB2562241B (en) 2017-05-08 2022-04-06 Stabilitech Biopharma Ltd Vaccine compositions
WO2020067453A1 (ja) 2018-09-28 2020-04-02 大日本住友製薬株式会社 注射用組成物
MX2021003938A (es) 2018-10-05 2021-08-11 Int Inst Cancer Immunology Inc Composicion para prevenir o tratar un tumor benigno.
CA3127312A1 (en) * 2019-02-13 2020-08-20 Sumitomo Dainippon Pharma Co., Ltd. Hemiasterlin derivative having cysteine residue
CN113905758A (zh) 2019-04-05 2022-01-07 大日本住友制药株式会社 水溶性佐剂和含有其的组合物
CA3136182A1 (en) 2019-04-05 2020-10-08 Sumitomo Dainippon Pharma Co., Ltd. Water soluble adjuvant
CN115867303A (zh) 2020-05-12 2023-03-28 住友制药株式会社 用于治疗癌症的药物组合物
TW202315645A (zh) 2021-08-12 2023-04-16 日商癌免疫研究所股份有限公司 用以處置或預防癌症之醫藥組合物及方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858358A (en) * 1992-04-07 1999-01-12 The United States Of America As Represented By The Secretary Of The Navy Methods for selectively stimulating proliferation of T cells
US6297041B1 (en) * 1992-03-11 2001-10-02 Institute Of Virology, Slovak Academy Of Sciences MN gene and protein
US6309642B1 (en) * 1997-04-28 2001-10-30 The Research And Development Institute, Inc. Peptides which mimic candida carbohydrate epitopes and their use in a vaccine
US5858682A (en) * 1996-08-02 1999-01-12 Pharmingen E2A/pbx1 fusion protein specific monoclonal antibodies
ATE420112T1 (de) * 1998-07-31 2009-01-15 Int Inst Cancer Immunology Inc Krebsantigene, basierend auf dem tumorunterdrückenden genprodukt wt1
JP4243792B2 (ja) 1998-09-30 2009-03-25 コリクサ コーポレイション Ｗｔ１特異的免疫療法のための組成物および方法
GB9823897D0 (en) 1998-11-02 1998-12-30 Imp College Innovations Ltd Immunotherapeutic methods and molecules
US7534605B2 (en) * 1999-06-08 2009-05-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
ATE383375T1 (de) * 2001-03-22 2008-01-15 Int Inst Cancer Immunology Inc Wti-modifiziertes peptid
AU2002252638A1 (en) * 2001-04-17 2002-10-28 Children's Hospital Oakland Research Institute Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies
JPWO2003028758A1 (ja) * 2001-09-28 2005-01-13 治夫 杉山 抗原特異的ｔ細胞の誘導方法
WO2003028757A1 (fr) 2001-09-28 2003-04-10 Haruo Sugiyama Nouvelle methode pour induire des lymphocytes t specifiques d'antigenes
AU2003242305A1 (en) * 2002-06-12 2003-12-31 Chugai Seiyaku Kabushiki Kaisha Hla-a24-restricted cancer antigen peptide
JP4611022B2 (ja) 2002-09-12 2011-01-12 株式会社癌免疫研究所 癌抗原ペプチド製剤
ES2331305T3 (es) 2002-09-20 2009-12-29 International Institute Of Cancer Immunology, Inc. Peptidos de wt1 de tipo sustituido.
CN1735864A (zh) * 2003-01-13 2006-02-15 施克莱无线公司 主机可扩展无线应用接口
AU2004204031B2 (en) * 2003-01-15 2010-03-04 International Institute Of Cancer Immunology, Inc. Dimerized peptide
ATE538809T1 (de) * 2003-06-27 2012-01-15 Int Inst Cancer Immunology Inc Verfahren zur auswahl von geeigneten patienten für den wt1-impfstoff
PL2071028T3 (pl) 2003-11-05 2012-06-29 Int Inst Cancer Immunology Inc Pochodzący z WT1 peptyd antygenowy wiążący się z HLA-DR
US7815918B2 (en) * 2003-12-31 2010-10-19 University Of Rochester Polypeptides and immunogenic conjugates capable of inducing antibodies against pathogens, and uses thereof
PT1731605E (pt) 2004-03-31 2010-04-14 Int Inst Cancer Immunology Inc Péptidos antigénicos de cancro derivados de wt1
US7241580B2 (en) * 2004-06-08 2007-07-10 Wisconsin Alumni Research Foundation Immunoaffinity chromatography using epitope tags to polyol-responsive monoclonal antibodies
SI1961761T1 (sl) * 2005-11-30 2010-12-31 Int Inst Cancer Immunology Inc Nove peptidne spojine iz Wilmsovega tumorja

Also Published As

Publication number Publication date
DK1961761T3 (da) 2010-11-29
RU2424247C2 (ru) 2011-07-20
AU2006319892B2 (en) 2012-05-10
TWI372152B (en) 2012-09-11
ES2352855T3 (es) 2011-02-23
JP2014080435A (ja) 2014-05-08
JP5597668B2 (ja) 2014-10-01
JP4394724B2 (ja) 2010-01-06
PL1961761T3 (pl) 2011-04-29
RU2008126305A (ru) 2010-01-10
US9765114B2 (en) 2017-09-19
US7939627B2 (en) 2011-05-10
DE602006017880D1 (xx) 2010-12-09
TW200730540A (en) 2007-08-16
WO2007063903A1 (ja) 2007-06-07
JP2012158597A (ja) 2012-08-23
PT1961761E (pt) 2010-12-16
BRPI0619255A2 (pt) 2011-09-27
JP5800928B2 (ja) 2015-10-28
BRPI0619255B1 (pt) 2021-05-11
EP1961761A4 (en) 2009-01-21
BRPI0619255B8 (pt) 2021-05-25
EP1961761B1 (en) 2010-10-27
BRPI0619255A8 (pt) 2015-12-15
US8575308B2 (en) 2013-11-05
KR101385805B1 (ko) 2014-04-16
US20110229506A1 (en) 2011-09-22
JP2009286792A (ja) 2009-12-10
US20140046036A1 (en) 2014-02-13
SI1961761T1 (sl) 2010-12-31
JPWO2007063903A1 (ja) 2009-05-07
CN105315347A (zh) 2016-02-10
CN101336249A (zh) 2008-12-31
CA2631292A1 (en) 2007-06-07
CA2631292C (en) 2014-05-06
US9273148B2 (en) 2016-03-01
EP1961761A1 (en) 2008-08-27
HK1221230A1 (zh) 2017-05-26
AU2006319892A1 (en) 2007-06-07
US20160168197A1 (en) 2016-06-16
US20100062010A1 (en) 2010-03-11
KR20080073356A (ko) 2008-08-08
JP5049323B2 (ja) 2012-10-17

Similar Documents

Publication Publication Date Title
HK1122819A1 (en) Novel peptide compounds from wilms' tumor
IL246171A0 (en) Peptide-based compounds
HK1090350A1 (en) Novel aminobenzophenone compounds
EP1966235A4 (en) ANTIMICROBIAL PEPTIDES OF CATHELICIDINE
IL183513A0 (en) Triazole substituted aminobenzophenone compounds
EP1824976A4 (en) ANTIMICROBIAL PEPTIDES
HK1114777A1 (en) Novel antimicrobial peptides
GB0304424D0 (en) Novel compounds
EP1596860A4 (en) NEW CONNECTIONS
EP1648885A4 (en) NEW CONNECTIONS
EP1939286A4 (en) NEW PEPTIDE
GB0302546D0 (en) Novel compounds
GB0302431D0 (en) Novel compounds
EP1635834A4 (en) NEW COMPOUNDS
HK1117152A1 (en) Triazole substituted aminobenzophenone compounds
SI1828148T1 (sl) S triazolom nadomeĺ äśeni aminobenzofenonski sestavki
GB0413812D0 (en) Compound libraries 9
GB0418182D0 (en) Compound libraries 14
GB0418183D0 (en) Compound libraries 15
GB0414058D0 (en) Compound libraries 12
PL1658263T3 (pl) Nowe związki aminobenzofenonowe
GB0301872D0 (en) Novel compounds
GB0304408D0 (en) Novel compounds
GB0301608D0 (en) Novel compounds
GB0301593D0 (en) Novel compounds